September 28, 2017
NOHLA THERAPEUTICS AWARDED $6.9 MILLION GRANT FROM THE CALIFORNIA INSTITUTE OF REGENERATIVE MEDICINE TO FURTHER DEVELOP NLA101 CELL THERAPY FOR THE TREATMENT OF PATIENTS WITH ACUTE MYELOID LEUKEMIA
DOWNLOAD PDF
May 16, 2017
NOHLA THERAPEUTICS PRESIDENT AND CEO, KATIE FANNING, TO PRESENT AT 2017 LIFE SCIENCE INNOVATION NORTHWEST CONFERENCE
DOWNLOAD PDF
March 28, 2017
NOHLA THERAPEUTICS ANNOUNCES COLLABORATION WITH UNIVERSITY OF CALIFORNIA, DAVIS TO OPTIMIZE MANUFACTURING PROCESS AND SUPPLY CELL THERAPY PRODUCT FOR CLINICAL TRIALS
DOWNLOAD PDF
February 14, 2017
NOHLA THERAPEUTICS TO PRESENT AT THE COWEN AND COMPANY 37TH ANNUAL HEALTH CARE CONFERENCE ON MARCH 7TH, 2017
DOWNLOAD PDF
February 8, 2017
GOVERNOR JAY INSLEE LEADS RIBBON CUTTING CEREMONY AT NOHLA’S SEATTLE HEADQUARTERS
DOWNLOAD PDF
February 2, 2017
NOHLA THERAPEUTICS APPOINTS KATHLEEN FANNING AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
DOWNLOAD PDF
November 30, 2016
NOHLA THERAPEUTICS APPOINTS SHELLY HEIMFELD, PH.D., EXECUTIVE VICE PRESIDENT OF RESEARCH AND MANUFACTURING
DOWNLOAD PDF
November 29, 2016
NOHLA THERAPEUTICS ANNOUNCES CLOSING OF $43.5M SERIES A FINANCING TO TRANSFORM STEM CELL TRANSPLANTATION WITH INNOVATIVE OFF THE SHELF, UNIVERSAL DONOR CELLULAR THERAPY
DOWNLOAD PDF
October 19, 2016
NOHLA THERAPEUTICS SIGNS EXCLUSIVE SUPPLY AGREEMENT WITH LIFESOUTH COMMUNITY BLOOD CENTERS
DOWNLOAD PDF
December 23, 2015
NOHLA THERAPEUTICS CLOSES OVERSUBSCRIBED US$21M PRIVATE FINANCING ROUND AND STRENGTHENS BOARD WITH NEW APPOINTMENT
DOWNLOAD PDF
December 3, 2015
NOHLA THERAPEUTICS LAUNCHES WITH MAJOR US CANCER RESEARCH INSTITUTE DEAL, SUBSTANTIAL INVESTMENT ROUND, AND KEY APPOINTMENTS
DOWNLOAD PDF
JULY 16, 2018
NOHLA THERAPEUTICS RECEIVES FDA ORPHAN DRUG DESIGNATION FOR DILANUBICEL FOR HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS
DOWNLOAD PDF
JULY 11, 2018
NOHLA THERAPEUTICS ANNOUNCES SECOND CLOSING OF $56 MILLION SERIES B FINANCING
DOWNLOAD PDF
JUNE 15, 2018
NOHLA ANNOUNCES PRESENTATION OF DILANUBICEL (NLA101) DATA AT EHA SHOWCASING EXCELLENT LONG-TERM SURVIVAL OUTCOMES
DOWNLOAD PDF
JUNE 6, 2018
NOHLA RECEIVES EMA PRIME DESIGNATION FOR DILANUBICEL (NLA101) TO TREAT HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS
DOWNLOAD PDF
May 17, 2018
NOHLA THERAPEUTICS ANNOUNCES EHA ABSTRACT ACCEPTANCE ON DILANUBICEL (NLA101) OFF-THE-SHELF CELL THERAPY SHOWING EXCELLENT LONG-TERM SURVIVAL OUTCOMES
DOWNLOAD PDF
May 15, 2018
NOHLA THERAPEUTICS ANNOUNCES CLOSING OF $45 MILLION SERIES B FINANCING
DOWNLOAD PDF
April 23, 2018
NOHLA THERAPEUTICS ANNOUNCES HIRING OF GARY CHRISTIANSON AS CHIEF OPERATING OFFICER
DOWNLOAD PDF
March 21, 2018
NOHLA THERAPEUTICS SELECTS ADVANCED THERAPIES BUSINESS UNIT OF WUXI APPTEC TO MANUFACTURE UNIVERSAL DONOR CELL THERAPIES
DOWNLOAD PDF
February 13, 2018
NOHLA THERAPEUTICS INITIATES GLOBAL LAUNCH PHASE 2 TRIAL OF NLA101 IN PATIENTS WITH AML
DOWNLOAD PDF
January 23, 2018
NOHLA THERAPEUTICS GRANTED ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR NLA101 IN THE TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
DOWNLOAD PDF
January 4, 2018
NOHLA THERAPEUTICS ANNOUNCES HIRING OF JIM JOHNSON AS CHIEF FINANCIAL OFFICER
DOWNLOAD PDF
In The News
May 15, 2018
Arch Leads Nohla’s $45M Series B
February 28, 2018
Nohla’s Dr. Colleen Delaney Receives AWIS Award
February 20, 2018
Nohla Initiates Phase 2 AML Trial Using Karius Test for Pathogen Detection
March 28, 2017
Nohla and UC Davis Ink Manufacturing Deal for Off-the-Shelf Donor Stem Cell Therapy
February 9, 2017
Inside Nohla’s New Seattle Biotech Lab as Gov. Jay Inslee Geeks Out on Science
December 2, 2016
Nohla Therapeutics closes $44 million funding round to support clinical trials
March 1, 2016
Commercialized Cord Blood
December 4, 2015
10 companies to watch
December 3, 2015
Nohla Therapeutics Launches with Major US Cancer Research Institute Deal, Substantial Investment Round, and Key Appointments
December 3, 2015
Startup Nohla Therapeutics to build on Hutch cord-blood work
December 3, 2015
Fred Hutchinson Cancer Research Center spins out disease-fighting biotech startup Nohla Therapeutics
December 3, 2015
New Fred Hutch spinoff to commercialize cord blood stem cell therapies based on work by Drs. Colleen Delaney, Irwin Bernstein
December 3, 2015
Cell therapy upstart lines up for a $20M round with the Hutch in tow